Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Oral Famciclovir Versus Aciclovir Treatment in Patients With Herpes Zoster

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients must be able to understand the study procedures, agree to participate and give written consent.~* Patients with clinical diagnosis of Herpes Zoster;~* Score higher than 4 for at least for 2 symptoms of Herpes Zoster;~* Negative pregnant urine test~Exclusion Criteria:~* Pregnancy or risk of pregnancy.~* Lactation~* Any pathology or past medical condition that can interfere with this protocol.~* Non-steroidal anti-inflammatory drug , hormonal anti-inflammatory or immunosuppressive drugs (in the last 30 days and during the study);~* Patients with immunodeficiency and/or immunosuppressive disease;~* Hypersensitivity to components of the formula;~* Other conditions deemed reasonable by the medical investigator as to the disqualification of the individual from study participation.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Famciclovir 500mg (Type: EXPERIMENTAL): 1 tablet each 8 hours for 7 days
- Aciclovir 400mg (Type: ACTIVE_COMPARATOR): 2 tablets of Aciclovir 400 mg each 4 hours for 7 days

Based on this trial design, predict the completion outcome and termination type (if applicable).